CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells

Por Duan, Zhenfeng, Ames, Rachel, Ryan, Meagan, Hornicek, Francis J., Mankin, Henry, Seiden, Michael V.
Publicado em 2008

Biodistribution and Pharmacokinetic Analysis of Paclitaxel and Ceramide Administered in Multifunctional Polymer-Blend Nanoparticles in Drug Resistant Breast Cancer Model

Por van Vlerken, Lilian E., Duan, Zhenfeng, Little, Steven R., Seiden, Michael V., Amiji, Mansoor M.
Publicado em 2008

Augmentation of Therapeutic Efficacy in Drug-Resistant Tumor Models Using Ceramide Coadministration in Temporal-Controlled Polymer-Blend Nanoparticle Delivery Systems

Por van Vlerken, Lilian E., Duan, Zhenfeng, Little, Steven R., Seiden, Michael V., Amiji, Mansoor M.
Publicado em 2010

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primar...

Por Lenzi, Renato, Edwards, Robert, June, Carl, Seiden, Michael V, Garcia, Michael E, Rosenblum, Michael, Freedman, Ralph S
Publicado em 2007

Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer

Por Pieretti-Vanmarcke, Rafael, Donahoe, Patricia K., Pearsall, Lisa A., Dinulescu, Daniela M., Connolly, Denise C., Halpern, Elkan F., Seiden, Michael V., MacLaughlin, David T.
Publicado em 2006

TEN-YEAR FOLLOW UP OF A PHASE II STUDY OF DOSE-INTENSE PACLITAXEL WITH CISPLATIN AND CYCLOPHOSPHAMIDE AS INITIAL THERAPY FOR POOR-PROGNOSIS ADVANCED-STAGE EPITHELIAL OVARIAN CANCER

Por Sarosy, Gisele A., Hussain, Mahrukh M., Seiden, Michael V., Fuller, A.F., Nikrui, N., Goodman, Annekathryn, Minasian, Lori, Reed, Eddie, Steinberg, Seth M., Kohn, Elise C.
Publicado em 2010

Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer

Por Konstantinopoulos, Panagiotis A., Cannistra, Stephen A., Fountzilas, Helen, Culhane, Aedin, Pillay, Kamana, Rueda, Bo, Cramer, Daniel, Seiden, Michael, Birrer, Michael, Coukos, George, Zhang, Lin, Quackenbush, John, Spentzos, Dimitrios
Publicado em 2011

Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients With Primary Ovarian Serous Carcinoma

Por Gillet, Jean-Pierre, Calcagno, Anna Maria, Varma, Sudhir, Davidson, Ben, Bunkholt Elstrand, Mari, Ganapathi, Ram, Kamat, Aparna A., Sood, Anil K., Ambudkar, Suresh V., Seiden, Michael V., Rueda, Bo R., Gottesman, Michael M.
Publicado em 2012

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

Por Hodi, F. Stephen, Mihm, Martin C., Soiffer, Robert J., Haluska, Frank G., Butler, Marcus, Seiden, Michael V., Davis, Thomas, Henry-Spires, Rochele, MacRae, Suzanne, Willman, Ann, Padera, Robert, Jaklitsch, Michael T., Shankar, Sridhar, Chen, Teresa C., Korman, Alan, Allison, James P., Dranoff, Glenn
Publicado em 2003

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

Por Hodi, F. Stephen, Butler, Marcus, Oble, Darryl A., Seiden, Michael V., Haluska, Frank G., Kruse, Andrea, MacRae, Suzanne, Nelson, Marybeth, Canning, Christine, Lowy, Israel, Korman, Alan, Lautz, David, Russell, Sara, Jaklitsch, Michael T., Ramaiya, Nikhil, Chen, Teresa C., Neuberg, Donna, Allison, James P., Mihm, Martin C., Dranoff, Glenn
Publicado em 2008